EDGAR Filing Documents for 0001193125-10-106730

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-10-106730

Filing Date

2010-05-04

Accepted

2010-05-04 17:08:36

Documents

Period of Report

2010-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	666275
2	FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT (FOR DIRECTORS)	dex101.htm	EX-10.1	29675
3	FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT (FOR OFFICERS)	dex102.htm	EX-10.2	31646
4	TECHNICAL TRANSFER & DEVELOPMENT SERVICES AGREEMENT	dex103.htm	EX-10.3	264419
5	EXECUTIVE EMPLOYMENT AGREEMENT	dex104.htm	EX-10.4	136979
6	CERTIFICATION OF THE PRESIDENT & CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	10585
7	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER & TREASURER	dex312.htm	EX-31.2	10607
8	CERTIFICATION OF THE PRESIDENT & CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.	dex321.htm	EX-32.1	4367
9	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER & TREASURER PURSUANT TO 18 U.S.C.	dex322.htm	EX-32.2	4388
	Complete submission text file	0001193125-10-106730.txt		1160358

Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466

Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777

INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)